Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Peihua Niu and Wenjie Tan.
Peihua Niu
Connection Strength
4.436
Wenjie Tan
  1. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient. J Infect Dis. 2018 09 08; 218(8):1249-1260.
    View in: PubMed
    Score: 0.785
  2. A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice. Sci China Life Sci. 2018 Oct; 61(10):1280-1282.
    View in: PubMed
    Score: 0.780
  3. [Development of Novel Multiplex Real-time RT-PCR Assays for Detection of MERS-CoV Infection]. Bing Du Xue Bao. 2016 05; 32(3):349-54.
    View in: PubMed
    Score: 0.667
  4. Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses. Virol Sin. 2016 Feb; 31(1):85-8.
    View in: PubMed
    Score: 0.655
  5. Profiles of SARS-CoV-2 RNA and Antibodies in Inpatients with COVID-19 not Related with Clinical Manifestation: A Single Centre Study. Virol Sin. 2021 10; 36(5):1088-1092.
    View in: PubMed
    Score: 0.238
  6. A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity. Signal Transduct Target Ther. 2021 05 31; 6(1):213.
    View in: PubMed
    Score: 0.237
  7. Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China. Protein Cell. 2021 01; 12(1):4-6.
    View in: PubMed
    Score: 0.230
  8. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 02 22; 395(10224):565-574.
    View in: PubMed
    Score: 0.216
  9. [A novel one-tube multiplex RT-PCR assay for simultaneous detection of six human coronaviruses]. Zhonghua Yu Fang Yi Xue Za Zhi. 2014 May; 48(5):416-9.
    View in: PubMed
    Score: 0.145
  10. Reply to "Novaferon, treatment in COVID-19 patients". Int J Infect Dis. 2021 02; 103:336-337.
    View in: PubMed
    Score: 0.057
  11. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat Commun. 2020 09 04; 11(1):4417.
    View in: PubMed
    Score: 0.056
  12. SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial. Int J Infect Dis. 2020 Oct; 99:84-91.
    View in: PubMed
    Score: 0.056
  13. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 07 28; 71(15):732-739.
    View in: PubMed
    Score: 0.056
  14. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
    View in: PubMed
    Score: 0.055
  15. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe. 2020 03 11; 27(3):325-328.
    View in: PubMed
    Score: 0.054
  16. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 02 20; 382(8):727-733.
    View in: PubMed
    Score: 0.054
  17. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein. Nat Commun. 2019 07 11; 10(1):3068.
    View in: PubMed
    Score: 0.052
  18. [Clinical and Biological Character in Mouse Models for Middle East Respiratory Syndrome Generated by Transduction with Different Doses of DPP4 Molecule]. Bing Du Xue Bao. 2015 Nov; 31(6):593-600.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.